MedImmune Message Board - Msg: 23483427

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sim1 who wrote (400)	4/22/2007 11:54:03 PM
From: sim1	Read Replies (1) of 416

AstraZeneca PLC Near The Purchase Of MedImmune [Copied (filched) from another board. Anyone have access to the wsj?] NEW YORK (Dow Jones)--Britain's AstraZeneca PLC (AZN)was Sunday night near the purchase of MedImmune Inc. (MEDI), for what could be more than $13 billion, people familiar with the negotiations said last night, The Wall Street Journal has learned. Barring any last minute snags, the transaction could be announced as early as Monday morning, these people added. (This story and related background material will be available on The Wall Street Journal Web site, WSJ.com.) The deal is the most significant for the British company since Astra AB and Zeneca Group first combined in 1999. A transaction would bring to an end a tumultuous ride for MedImmune, which is prized for its collection of drugs for respiratory viruses and influenza, but whose stock faltered during 2006 and came under pressure from investor Carl Icahn. But Mr. Icahn and a group of other investors proved to be right when they said the company would fetch a steep price from the world's major pharmaceutical companies, who are desperate to bring new growth into their businesses.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next